BDC2.5 mimotope 1040-31 is a strong agonistic peptide for diabetogenic T cell clone BDC2.5, and the 1040-31 peptide is specific for BDC 2.5 TCR Tg+ T cells.
CAT No: R1235
CAS No:329696-49-3
Synonyms/Alias:BDC2.5 mimotope 1040-31;329696-49-3;PD159297;G13745;
BDC2.5 mimotope 1040-31 is a synthetic peptide that serves as a functional analog of an endogenous antigen recognized by the BDC2.5 T-cell receptor, primarily studied in murine models of autoimmune diabetes. As a peptide compound, it is designed to mimic the native epitope involved in T-cell mediated immune responses, offering a valuable tool for dissecting antigen-specific cellular interactions. Its precise sequence and structural features allow researchers to probe molecular mechanisms underlying T-cell activation, antigen specificity, and the pathogenesis of autoimmune processes. The use of such mimotopes has become increasingly significant in immunological research, particularly for elucidating the dynamics of autoreactive T-cell populations and for the development of experimental models that mirror human disease states.
Autoimmunity research: In the context of autoimmune diabetes, the mimotope is widely employed to investigate the cellular and molecular basis of T-cell recognition and activation. By presenting the peptide to BDC2.5 T-cells, researchers can monitor antigen-specific responses, cytokine production, and proliferation, thereby gaining insights into the mechanisms that drive pancreatic beta cell destruction. This approach enables the characterization of autoreactive T-cell repertoires and supports studies aiming to identify critical checkpoints in the progression of autoimmune pathology.
Epitope mapping: The sequence-specific nature of 1040-31 allows it to serve as a precise probe for delineating the antigenic determinants recognized by disease-relevant T-cell clones. Through peptide titration assays, alanine scanning, or competitive binding experiments, investigators can map the minimal epitope required for T-cell activation. Such studies are essential for understanding how minor sequence variations influence immune recognition and for identifying potential molecular targets for immunomodulation.
T-cell functional assays: The mimotope is frequently utilized in assays designed to assess T-cell functionality, including proliferation, cytotoxicity, and cytokine secretion. By providing a defined peptide stimulus, researchers can standardize experimental conditions and reliably evaluate the responsiveness of T-cell populations derived from transgenic or wild-type animals. This facilitates comparative analyses across experimental groups and supports the optimization of in vitro and ex vivo immunological assays.
Antigen presentation studies: The peptide's well-characterized sequence and immunogenicity make it a valuable tool for exploring antigen processing and presentation mechanisms. Researchers can use it to evaluate the efficiency of antigen-presenting cells, such as dendritic cells or macrophages, in presenting the mimotope via major histocompatibility complex (MHC) molecules. These studies contribute to a deeper understanding of the cellular interactions that govern immune activation and tolerance, particularly in the context of autoantigen presentation.
Peptide-based tolerance induction: In experimental models, the use of synthetic mimotopes like 1040-31 supports research into tolerance induction strategies. By administering the peptide under controlled conditions, investigators can assess the potential for modulating autoreactive T-cell responses, either through anergy, deletion, or regulatory T-cell expansion. Such studies are pivotal for advancing the development of antigen-specific immunotherapies and for elucidating the parameters that dictate immune tolerance versus autoimmunity.
2. Implications of ligand-receptor binding kinetics on GLP-1R signalling
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More